Intraobserver and interobserver variability of renal volume measurements in polycystic kidney disease using a semiautomated MR segmentation algorithm.

OBJECTIVE Total renal volume and changes in kidney volume are markers of disease progression in autosomal-dominant polycystic kidney disease (ADPKD) but are not used in clinical practice in part because of the complexity of manual measurements. This study aims to assess the intra- and interobserver reproducibility of a semiautomated renal volumetric algorithm using fluid-sensitive MRI pulse sequences. SUBJECTS AND METHODS Renal volumes of 17 patients with ADPKD were segmented from high-resolution coronal HASTE and true fast imaging with steady-state precession (FISP) MR acquisitions. Measurements performed independently by four readers were repeated, typically after 7 days. Intraobserver agreement indexes were calculated for total kidney volume for each patient. Interobserver agreement indexes were obtained for the six paired combinations of readers as well as for two readers after rigorous formalized training. Pearson and concordance correlation coefficients, coefficients of variation (CVs), and 95% limits of agreement were determined. RESULTS The HASTE and true FISP sequences performed similarly with a median intraobserver agreement of greater than 98.1% and a CV of less than 2.4% across all readers. The median interobserver agreement was greater than 95.2% and the CV was less than 7.1%, across all reader pairs. Reader training further lowered interobserver CV. The mean total kidney volume was 1420 mL (range, 331-3782 mL) for HASTE imaging and 1445 mL (range, 301-3714 mL) for true FISP imaging, with mean image processing times per patient of 43 and 28 minutes, respectively. CONCLUSION This semiautomated MR volumetric algorithm provided excellent intraobserver and very good interobserver reproducibility using fluid-sensitive pulse sequences that emphasize cyst conspicuity.

[1]  Oliver Senn,et al.  Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months. , 2009, Kidney international.

[2]  Richard H Cohan,et al.  Prevention of contrast-induced nephropathy: an overview. , 2009, Radiologic clinics of North America.

[3]  J. Weinreb,et al.  Nephrogenic systemic fibrosis. , 2009, Magnetic resonance imaging clinics of North America.

[4]  L H Wetzel,et al.  Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography. , 2000, Kidney international.

[5]  V. Torres,et al.  Autosomal dominant polycystic kidney disease. , 2003, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[6]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[7]  P. Wilson,et al.  Polycystic kidney disease. , 2004, The New England journal of medicine.

[8]  R. Schrier Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease. , 2009, Journal of the American Society of Nephrology : JASN.

[9]  A. Chapman,et al.  Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. , 2005, Clinical journal of the American Society of Nephrology : CJASN.

[10]  L M Cruz-Orive,et al.  Measuring error and sampling variation in stereology: comparison of the efficiency of various methods for planar image analysis , 1981, Journal of microscopy.

[11]  V. Torres,et al.  Autosomal dominant polycystic kidney disease: the last 3 years. , 2009, Kidney international.

[12]  Tom Greene,et al.  Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the Modification of Diet in Renal Disease study equation for estimating glomerular filtration rate (Annals of Internal Medicine (2006) 145, (247-254)) , 2008 .

[13]  B F King,et al.  Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease. , 2000, Journal of the American Society of Nephrology : JASN.

[14]  Paul A Thompson,et al.  Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. , 2003, Kidney international.

[15]  J. Miller,et al.  The HALT polycystic kidney disease trials: design and implementation. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[16]  J. Stockman,et al.  Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease , 2012 .

[17]  A. Chapman Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[18]  P K Commean,et al.  Volumetric Measurement of Renal Cysts and Parenchyma Using MRI: Phantoms and Patients with Polycystic Kidney Disease , 2000, Journal of computer assisted tomography.

[19]  L. Tanoue Computed Tomography — An Increasing Source of Radiation Exposure , 2009 .

[20]  Kyu-Beck Lee,et al.  Reliability of Magnetic Resonance Imaging for Measuring the Volumetric Indices in Autosomal-Dominant Polycystic Kidney Disease: Correlation with Hypertension and Renal Function , 2006, Nephron Clinical Practice.

[21]  M. Klein,et al.  Volume Progression in Polycystic Kidney Disease , 2007 .

[22]  J. Miller,et al.  Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP). , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  Ann M. Johnson,et al.  Renal structure and hypertension in autosomal dominant polycystic kidney disease. , 1990, Kidney international.

[24]  A. Takakura,et al.  Polycystic Kidney Disease Evaluation by Magnetic Resonance Imaging in Ischemia-Reperfusion Injured PKD1 Knockout Mouse Model: Comparison of T2-Weighted FSE and True-FISP , 2010, Investigative radiology.

[25]  M J Puddephat,et al.  The benefit of stereology for quantitative radiology. , 2000, The British journal of radiology.

[26]  J. Grantham,et al.  Polycystic kidney disease: from the bedside to the gene and back , 2001, Current opinion in nephrology and hypertension.

[27]  K. Bae,et al.  MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[28]  Ann M. Johnson,et al.  Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease , 1992, Pediatric Nephrology.